Michael W. Deininger, MD, PhD¹, Jane F Apperley, FRCP, FRCPath, MB ², Christopher Kevin Arthur, MBBS, FRACP, FRCPA³, Charles Chuah⁴, Andreas Hochhaus, MD⁵, Hugues De Lavallade^6*, Jeffrey H. Lipton, MD, PhD⁷, Elza Lomaia, MD, PhD^8*, James K McCloskey, MD⁹, Lori J. Maness, MD¹⁰, Michael J. Mauro, MD¹¹, Beatriz Moiraghi, MD^12*, Carolina Pavlovsky^13*, Gianantonio Rosti^14*, Philippe Rousselot^15*, Soledad S. Undurraga, MD¹⁶, Vickie Lu, PhD^17*, Alexander Vorog, MD^17* and Jorge E. Cortes, MD¹⁸

¹Division of Hematology and Hematologic Malignancies, University of Wisconsin Milwaukee, Milwaukee, WI
²Imperial College London, London, United Kingdom
³Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia
⁴Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore
⁵Univerisitätsklinikum Jena, Jena, Germany
⁶King's College Hospital NHS Foundation, London, United Kingdom
⁷Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, Canada
⁸Almazov National Medical Research Centre, St. Petersburg, Russian Federation
⁹Division of Leukemia, John Thuerer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
¹⁰Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
¹¹Memorial Sloan-Kettering Cancer Center, New York, NY
¹²Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina
¹³Fundaleu, Buenos Aires, Argentina
¹⁴IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
¹⁵Centre Hospitalier de Versailles University de Versailles Saint-Quentin-en-Yvelines, Paris, France
¹⁶Hospital Del Salvador, Santiago, CHL
¹⁷Takeda Development Center Americas, Inc., Lexington, MA
¹⁸Georgia Cancer Center Augusta University, Augusta, GA

Xiaoshuai Zhang^1*, Zongru Li^2*, Yazhen Qin^3*, Robert Peter Gale^4,5, Xiaojun Huang⁶ and Qian Jiang, MD⁷

¹Peking University People's Hospital, Beijing, China
²Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
³Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁴Haematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK, London, United Kingdom
⁵Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
⁶Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China
⁷Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, People’s Republic of China, Beijing, China

Jorge E. Cortes, MD¹, Tapan Saikia, MD², Dong-Wook Kim, M.D., Ph.D.^3,4, Yesid Alvarado, MD⁵, Franck E. Nicolini, MD, PhD⁶, Krishnakumar Rathnam, MD, DM^7*, Navin Khattry, MD, DM^8*, Jane F Apperley, FRCP, FRCPath, MB ⁹, Michael W. Deininger, MD, PhD^10,11, Hugues de Lavallade, MD, PhD^12*, Aude Charbonnier, MD^13*, Nikki Granacher, MD^14*, Carlo Gambacorti-Passerini, MD¹⁵, Alessandro Lucchesi, MD^16*, Michael J. Mauro, MD¹⁷, Peter Vandenberghe, MD, PhD¹⁸, Gregor Verhoef, MD, PhD^18*, Andrew R. Whiteley, MD¹⁹, Arijit Nag, MD, DM^20*, Vivek S Radhakrishnan, MD, DM, MSc²⁰, Shashikant Apte, MD, FRCPA²¹, Siu-Long Yao, MD²², Sandeep Inamdar, MBBS^23*, Jayasree Sreenivasan, MSc^23*, Ruchika Irene Dillu, MD^23* and Geetanjali Chimote, MD, PhD^23*

¹Georgia Cancer Center Augusta University, Augusta, GA
²Prince Aly Khan Hospital, Mumbai, India
³Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁴Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Hematology department, Centre Léon Bérard, Lyon, France
⁷Lake Area,Melur Main Rd, Meenakshi Mission Hospital and Research Centre, Tamil Nadu, India
⁸BMT unit, Department of Medical oncology, ACTREC., Tata Memorial Centre, Navi Mumbai, India
⁹Centre for Haematology, Department of Medicine, Hammersmith Hospital, Imperial College, London, ENG, United Kingdom
¹⁰Division of Hematology and Hematologic Malignancies, University of Wisconsin Milwaukee, Milwaukee, WI
¹¹Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT
¹²Department of Haematological Medicine, Kings College Hospital, NHS Foundation Trust, London, United Kingdom
¹³Departement d'Hematologie, Institut Paoli Calmettes, Marseille, France
¹⁴Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
¹⁵Dept of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
¹⁶Hematology Unit,, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), FC, Italy
¹⁷Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁸Department of Hematology, UZ Leuven, Leuven, Belgium
¹⁹Baylor University Medical Center, Dallas, TX
²⁰Clinical Hematology Oncology & HCT, Tata Medical Center, Kolkata, India
²¹Pune’s Sahyadri Hospital, Maharashtra, India
²²Sun Pharmaceutical Industries, Inc., Princeton, NJ
²³Sun Pharma Advanced Research Company Ltd, Mumbai, India

Michael J. Mauro, MD¹, Yosuke Minami, MD, PhD², Delphine Rea, MD, PhD³, Andreas Hochhaus, MD⁴, Elza Lomaia, MD, PhD^5*, Sergey Voloshin, MD, PhD^6*, Anna G. Turkina, Prof., MD⁷, Dong-Wook Kim, M.D., Ph.D.⁸, Jane F Apperley, FRCP, FRCPath, MB ⁹, Jorge E. Cortes, MD¹⁰, Andre N.R. Abdo, MD^11*, Laura Fogliatto¹², Dennis Dong Hwan Kim, MD, PhD^13*, Philipp D le Coutre, MD¹⁴, Susanne Saussele, MD ¹⁵, Mario Annunziata, MD^16*, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA¹⁷, Naeem A. Chaudhri, MD¹⁸, Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA¹⁹, Valentín Garcia Gutierrez, MD, PhD²⁰, Koji Sasaki, MD²¹, Shruti Kapoor^22*, Alex Allepuz, MD, MPH^23*, Sarah Quenet^24*, Véronique Bédoucha^24* and Carla Boquimpani, MD^25*

¹Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan
³Hopital Saint Louis, Paris, France
⁴Department of Internal Medicine II, Jena University Hospital, Jena, Germany
⁵Almazov National Medical Research Centre, St. Petersburg, Russian Federation
⁶Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russian Federation
⁷National Research Center for Hematology, Moscow, Russian Federation
⁸Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁹Centre for Haematology, Imperial College, London, United Kingdom
¹⁰Georgia Cancer Center Augusta University, Augusta, GA
¹¹Instituto do Câncerdo Estado de São Paulo (ICESPSP), São Paulo, Brazil
¹²Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
¹³Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, Canada
¹⁴Charité – Universitätsmedizin Berlin, Berlin, Berlin, Germany
¹⁵III. Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany
¹⁶Hematology Unit, Azienda Ospedaliera Cardarelli, Naples, Italy
¹⁷Precision Medicine Theme, South Australian Health and Medical Research Institute SAHMRI, Adelaide, SA, Australia
¹⁸Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
¹⁹Department of Clinical Haematology and Bone Marrow Transplant Service, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
²⁰Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
²¹Department of Leukemia, MD Anderson Cancer Center, Houston, TX
²²Novartis Pharmaceuticals Corporation, East Hanover, NJ
²³Novartis Pharma AG, Basel, NJ, Switzerland
²⁴Novartis Pharma AG, Basel, Switzerland
²⁵HEMORIO, State Institute of Hematology Arthur de Siquiera Cavalcanti, Rio de Janeiro, Brazil

Jiang Qian, MD¹, Dayu Shi^2*, Zongru Li^2*, Yazhen Qin^2*, Ting Zhao^2*, Bingcheng Liu^3*, Zi Chen^4,5*, Qian Niu^4,5*, Lichuang Men^4,5*, Hengbang Wang^4,6*, Dajun Yang^4,7*, Yifan Zhai^4,5,8 and Xiaojun Huang⁹

¹Peking University Institute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
²Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
³Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
⁴Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China
⁵Guangzhou Healthquest Pharma Co. Ltd., Guangzhou, China
⁶HealthQuest Pharma Inc., Guangzhou, China
⁷Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China
⁸Ascentage Pharma Group Inc., Rockville, MD
⁹Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing China, Beijing, China

Mhairi Copland, PhD, MBBChir, FRCP, FRCPath¹, Daniel Slade^2*, Graham McIlroy^2*, Gillian Horne^1*, Jennifer Byrne^3*, Kate Rothwell^4*, Kristian Brock^2*, Hugues De Lavallade^5*, Charles Craddock, FRCP, FRCPath⁶, Richard Clark^7*, Matthew Smith^8*, Rachel Fletcher^2*, Rebecca Bishop, BSc^2*, Dragana Milojkovic^9* and Christina Yap, BSc, MSc, PhD^2,10*

¹Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, United Kingdom
²Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
³Centre for Clinical Haematology, Nottingham University, Nottingham, ENG, United Kingdom
⁴Department of Clinical Heamatology, Leeds Teaching Hospitals NHS Trust, Leeds, ENG, United Kingdom
⁵Department of Haemato-Oncology, King's College Hospital NHS Foundation, London, United Kingdom
⁶Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, ENG, United Kingdom
⁷Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
⁸Department of Haemato-Oncology, St Bartholomew's Hospital, London, United Kingdom
⁹Centre for Haematology, Imperial College London, London, United Kingdom
¹⁰Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom